NCT00107354View on ClinicalTrials.gov

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1998

Primary Completion Date

August 31, 2009

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic allogeneic lymphocytes

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

cytarabine

DRUG

etoposide

DRUG

mitoxantrone hydrochloride

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
lead

Fred Hutchinson Cancer Center

OTHER

NCT00107354 - Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter